Hospital
Kettering Medical Center
Kettering Medical Center was paid $37.96M by Medicaid between Jan 2018 and Dec 2024, across 361 billing codes. Its largest line is 96361, Intravenous infusion, hydration; each additional hour — 16% of everything it billed.
33Billing provider infoKETTERING MEDICAL CENTER
KETTERING, OH 45429
KETTERING, OH 45429
33aNPI1043233984assigned 07/25/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$37.96M
24GClaims983,321
24DCodes billed361
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Ohio
Rank by total paid#30 of 101
Median peer was paid$22.32M
This provider vs. median1.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official KO, TIMOTHY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 44,118 | $1.53M | |
| 2019 | 62,277 | $2.45M | |
| 2020 | 51,316 | $2.65M | |
| 2021 | 71,159 | $3.49M | |
| 2022 | 93,461 | $3.90M | |
| 2023 | 368,550 | $14.25M | |
| 2024incomplete | 292,440 | $9.70M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 96361 | Intravenous infusion, hydration; each additional hour | 16% | 22,797 | 15,730 | $6.00M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 14% | 49,402 | 45,236 | $5.42M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 13% | 39,604 | 36,083 | $5.01M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7.2% | 21,357 | 18,344 | $2.75M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 3.2% | 13,165 | 10,832 | $1.21M |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 2.9% | 9,065 | 7,312 | $1.12M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.7% | 14,420 | 5,544 | $1.04M |
| 70450 | Computed tomography, head or brain; without contrast material | 2.7% | 5,056 | 4,074 | $1.03M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.6% | 4,878 | 4,082 | $1.00M |
| G0378 | Hospital observation service, per hour | 2.5% | 13,405 | 7,684 | $944K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.7% | 2,900 | 2,394 | $661K |
| 77386 | 1.5% | 2,145 | 179 | $579K |
349 more codes
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.4% | 3,324 | $527K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.4% | 4,599 | $514K |
| 76819 | Fetal biophysical profile; without non-stress testing | 1.2% | 5,786 | $451K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.2% | 4,585 | $448K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.1% | 2,349 | $420K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1.0% | 2,682 | $386K |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 731 | $349K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 1,484 | $321K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 63,367 | $307K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 2,744 | $271K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 8,237 | $267K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 2,273 | $262K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,885 | $261K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 390 | $235K |
| 59025 | Fetal non-stress test | <1% | 1,507 | $218K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 3,728 | $200K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 4,274 | $186K |
| 93356 | <1% | 954 | $185K | |
| 76642 | <1% | 1,380 | $159K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 10,326 | $157K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 1,714 | $155K |
| 95811 | <1% | 231 | $149K | |
| 95708 | <1% | 212 | $147K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 945 | $141K |
| 77336 | <1% | 1,503 | $140K | |
| 70496 | <1% | 684 | $133K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 508 | $129K |
| 97162 | <1% | 2,491 | $126K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 315 | $122K |
| 78431 | <1% | 278 | $120K | |
| 76820 | <1% | 1,947 | $117K | |
| 77300 | <1% | 329 | $110K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 526 | $100K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 2,582 | $100K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 4,402 | $94K |
| 77334 | <1% | 336 | $94K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 3,050 | $93K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 1,346 | $89K |
| 76830 | Ultrasound, transvaginal | <1% | 1,156 | $84K |
| 93970 | <1% | 690 | $79K | |
| 36224 | <1% | 31 | $76K | |
| 97161 | <1% | 1,391 | $68K | |
| 93971 | <1% | 1,148 | $68K | |
| 84484 | <1% | 25,720 | $66K | |
| 93017 | <1% | 908 | $63K | |
| 71250 | <1% | 879 | $61K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 5,765 | $60K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 531 | $56K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 2,545 | $53K |
| 93458 | <1% | 46 | $51K | |
| 12001 | <1% | 371 | $50K | |
| 72131 | <1% | 1,134 | $50K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 352 | $48K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 78,732 | $46K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,909 | $45K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 32,419 | $43K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 4,692 | $42K |
| 19083 | <1% | 84 | $39K | |
| 88307 | <1% | 744 | $38K | |
| 82805 | <1% | 1,903 | $38K | |
| 71045 | Radiologic examination, chest; single view | <1% | 18,754 | $38K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 297 | $35K |
| 70491 | <1% | 129 | $35K | |
| 80053 | Comprehensive metabolic panel | <1% | 7,661 | $35K |
| 10060 | <1% | 246 | $35K | |
| 97165 | <1% | 940 | $34K | |
| 97166 | <1% | 1,007 | $32K | |
| J3490 | Unclassified drugs | <1% | 5,303 | $31K |
| 88341 | <1% | 832 | $30K | |
| 96367 | <1% | 922 | $30K | |
| 86850 | <1% | 2,072 | $30K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 1,914 | $29K |
| 80069 | <1% | 5,251 | $29K | |
| 80076 | <1% | 17,952 | $29K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 1,342 | $29K |
| 77065 | Tomosynthesis, mammo | <1% | 940 | $28K |
| G0257 | Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility | <1% | 218 | $27K |
| 88184 | <1% | 359 | $26K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 74 | $25K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 26,755 | $25K |
| 77066 | Tomosynthesis, mammo | <1% | 781 | $24K |
| 88185 | <1% | 622 | $23K | |
| 93325 | <1% | 297 | $23K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 311 | $23K |
| 58661 | <1% | 12 | $22K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 112 | $22K |
| P9045 | Infusion, albumin (human), 5%, 250 ml | <1% | 163 | $21K |
| 76536 | <1% | 211 | $21K | |
| 22551 | <1% | 20 | $20K | |
| 86900 | <1% | 2,327 | $20K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 20,975 | $17K |
| 76801 | <1% | 316 | $17K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 13,642 | $17K |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 774 | $17K |
| 97163 | <1% | 320 | $17K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 538 | $16K |
| 93880 | <1% | 223 | $16K | |
| 72132 | <1% | 207 | $16K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 362 | $14K |
| 72128 | <1% | 565 | $14K | |
| 74018 | <1% | 628 | $13K | |
| 70486 | <1% | 536 | $13K | |
| 72100 | <1% | 598 | $13K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 14,882 | $13K |
| 71271 | <1% | 86 | $13K | |
| 01999 | <1% | 1,160 | $13K | |
| 77301 | <1% | 41 | $13K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,193 | $12K |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 1,202 | $12K |
| 90715 | <1% | 923 | $11K | |
| 74183 | <1% | 41 | $11K | |
| 95700 | <1% | 109 | $11K | |
| 95816 | <1% | 92 | $11K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 20,058 | $10K |
| 36226 | <1% | 32 | $10K | |
| 80061 | Lipid panel | <1% | 1,393 | $10K |
| 73630 | <1% | 1,511 | $9K | |
| 73562 | <1% | 820 | $9K | |
| 73130 | <1% | 1,125 | $9K | |
| 73030 | <1% | 1,250 | $9K | |
| 94729 | <1% | 181 | $9K | |
| 92610 | <1% | 439 | $9K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 967 | $9K |
| 76825 | <1% | 57 | $9K | |
| 76937 | <1% | 230 | $9K | |
| 36227 | <1% | 58 | $9K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 36 | $9K |
| 81001 | <1% | 27,597 | $9K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 3,351 | $8K |
| 96376 | <1% | 6,299 | $8K | |
| 92523 | <1% | 298 | $8K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 377 | $8K |
| 94726 | <1% | 128 | $8K | |
| 95806 | <1% | 15 | $8K | |
| S9472 | Cardiac rehabilitation program, non-physician provider, per diem | <1% | 145 | $8K |
| 70498 | <1% | 667 | $7K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 487 | $7K |
| 72040 | <1% | 239 | $7K | |
| 77338 | <1% | 54 | $7K | |
| 83735 | <1% | 7,168 | $7K | |
| 12002 | <1% | 62 | $7K | |
| 85027 | <1% | 4,041 | $7K | |
| 97116 | <1% | 360 | $7K | |
| 85610 | <1% | 5,899 | $6K | |
| 82607 | <1% | 926 | $6K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,749 | $6K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 17 | $6K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,740 | $6K |
| 87529 | <1% | 2,806 | $6K | |
| 84439 | <1% | 804 | $6K | |
| 73610 | <1% | 1,180 | $6K | |
| 94060 | <1% | 55 | $6K | |
| 73560 | <1% | 722 | $5K | |
| 95861 | <1% | 25 | $5K | |
| 83880 | <1% | 2,282 | $5K | |
| 82728 | <1% | 651 | $5K | |
| 96368 | <1% | 285 | $5K | |
| 73502 | <1% | 555 | $5K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 31 | $5K |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | <1% | 401 | $5K |
| 80320 | <1% | 795 | $5K | |
| 76827 | <1% | 59 | $5K | |
| 88360 | <1% | 154 | $5K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,581 | $5K |
| 81025 | <1% | 14,051 | $5K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 4,696 | $4K |
| 78434 | <1% | 224 | $4K | |
| 84702 | <1% | 1,384 | $4K | |
| 77295 | <1% | 13 | $4K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,740 | $4K |
| 72141 | <1% | 30 | $4K | |
| 95937 | <1% | 51 | $4K | |
| 73700 | <1% | 48 | $4K | |
| 86140 | <1% | 740 | $4K | |
| 83690 | <1% | 14,263 | $4K | |
| 12011 | <1% | 28 | $4K | |
| 95938 | <1% | 52 | $3K | |
| 74174 | <1% | 34 | $3K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 1,648 | $3K |
| 86780 | <1% | 305 | $3K | |
| 83540 | <1% | 716 | $3K | |
| 73110 | <1% | 661 | $3K | |
| 86901 | <1% | 2,325 | $3K | |
| 75635 | <1% | 16 | $3K | |
| J2800 | Injection, methocarbamol, up to 10 ml | <1% | 1,006 | $3K |
| 76098 | <1% | 44 | $3K | |
| 76870 | <1% | 60 | $3K | |
| 76770 | <1% | 12 | $3K | |
| 83550 | <1% | 677 | $3K | |
| J7999 | Compounded drug, not otherwise classified | <1% | 1,892 | $3K |
| 00840 | <1% | 190 | $2K | |
| 95939 | <1% | 22 | $2K | |
| 95955 | <1% | 52 | $2K | |
| 87077 | <1% | 1,794 | $2K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 185 | $2K |
| 76775 | <1% | 26 | $2K | |
| 84100 | <1% | 1,880 | $2K | |
| 83605 | <1% | 3,491 | $2K | |
| 86803 | <1% | 140 | $2K | |
| 64488 | <1% | 13 | $2K | |
| 85378 | <1% | 2,963 | $2K | |
| 87634 | <1% | 918 | $2K | |
| 82248 | <1% | 910 | $2K | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | <1% | 787 | $2K |
| 88112 | <1% | 131 | $2K | |
| 87070 | <1% | 643 | $2K | |
| 82746 | <1% | 840 | $2K | |
| 94660 | <1% | 30 | $2K | |
| 73080 | <1% | 374 | $2K | |
| 99152 | <1% | 349 | $2K | |
| 73090 | <1% | 396 | $1K | |
| 73140 | <1% | 250 | $1K | |
| 87186 | <1% | 1,457 | $1K | |
| 84112 | <1% | 31 | $1K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 2,921 | $1K |
| 88342 | <1% | 1,434 | $1K | |
| 84145 | <1% | 1,790 | $1K | |
| 85730 | <1% | 1,956 | $1K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 12 | $1K |
| 73590 | <1% | 452 | $1K | |
| 72110 | <1% | 34 | $1K | |
| 87340 | <1% | 143 | $1K | |
| 81003 | <1% | 3,377 | $1K | |
| 29125 | <1% | 586 | $1K | |
| 85651 | <1% | 1,078 | $1K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 13 | $1K |
| 87210 | <1% | 1,024 | $1K | |
| 84132 | <1% | 1,433 | $1K | |
| 85014 | <1% | 433 | $1K | |
| 72129 | <1% | 30 | $1K | |
| 36430 | <1% | 22 | $979.24 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 3,222 | $976.91 |
| 72170 | <1% | 278 | $973.89 | |
| 97167 | <1% | 14 | $899.68 | |
| 87205 | <1% | 639 | $895.95 | |
| 82550 | <1% | 996 | $891.08 | |
| 85007 | <1% | 1,526 | $828.24 | |
| J8501 | Aprepitant, oral, 5 mg | <1% | 50 | $819.66 |
| 87040 | <1% | 2,884 | $814.29 | |
| 85018 | <1% | 636 | $803.83 | |
| 82575 | <1% | 189 | $793.35 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 25,419 | $749.98 |
| 82330 | <1% | 628 | $707.64 | |
| G0008 | Administration of influenza virus vaccine | <1% | 88 | $703.16 |
| 88304 | <1% | 762 | $697.31 | |
| 77080 | <1% | 13 | $686.19 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 3,136 | $648.36 |
| 85049 | <1% | 1,006 | $647.47 | |
| 71101 | <1% | 201 | $629.00 | |
| 36600 | <1% | 162 | $628.02 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 9,120 | $627.37 |
| 82140 | <1% | 518 | $622.17 | |
| 90686 | <1% | 46 | $549.65 | |
| G0238 | Therapeutic procedures to improve respiratory function, other than described by g0237, one on one, face to face, per 15 minutes (includes monitoring) | <1% | 50 | $541.88 |
| 73060 | <1% | 35 | $504.20 | |
| 84156 | <1% | 208 | $503.72 | |
| 86141 | <1% | 344 | $442.64 | |
| 72072 | <1% | 42 | $370.84 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 3,010 | $351.42 |
| 01400 | <1% | 21 | $337.15 | |
| 84703 | <1% | 425 | $318.73 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 1,595 | $257.02 |
| 73552 | <1% | 63 | $247.73 | |
| 86308 | <1% | 52 | $233.97 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 15,913 | $227.19 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 680 | $213.95 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 1,731 | $212.98 |
| 00400 | <1% | 69 | $212.23 | |
| 85347 | <1% | 490 | $211.60 | |
| 73564 | <1% | 12 | $197.64 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 597 | $197.48 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 6,054 | $195.48 |
| 82947 | <1% | 97 | $190.01 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 333 | $155.10 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | <1% | 246 | $152.18 |
| J2704 | Injection, propofol, 10 mg | <1% | 2,431 | $141.01 |
| 84481 | <1% | 12 | $140.61 | |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 774 | $138.17 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 2,696 | $137.82 |
| 88311 | <1% | 430 | $133.75 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,280 | $123.85 |
| 82010 | <1% | 585 | $122.44 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 790 | $121.41 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 1,262 | $121.37 |
| 83615 | <1% | 42 | $115.34 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 446 | $112.12 |
| 84550 | <1% | 32 | $98.55 | |
| A4648 | Tissue marker, implantable, any type, each | <1% | 522 | $97.56 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | <1% | 322 | $93.37 |
| J1790 | Injection, droperidol, up to 5 mg | <1% | 928 | $79.04 |
| 80074 | <1% | 14 | $74.25 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 335 | $73.88 |
| 36592 | <1% | 33 | $71.09 | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | <1% | 817 | $67.84 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,904 | $66.82 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 831 | $66.66 |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 461 | $66.10 |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 691 | $62.50 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 5,012 | $57.01 |
| J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | <1% | 924 | $54.23 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | <1% | 2,141 | $52.76 |
| 82565 | <1% | 37 | $38.54 | |
| 82040 | <1% | 26 | $33.97 | |
| 87075 | <1% | 36 | $32.92 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 986 | $27.68 |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 618 | $25.97 |
| J3360 | Injection, diazepam, up to 5 mg | <1% | 120 | $23.25 |
| 94761 | <1% | 567 | $22.50 | |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 124 | $20.83 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 53 | $16.84 |
| 81015 | <1% | 71 | $13.35 | |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 209 | $12.55 |
| Q0177 | Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 798 | $10.36 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 528 | $8.17 |
| J2470 | Injection, pantoprazole sodium, 40 mg | <1% | 209 | $6.97 |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | <1% | 51 | $4.34 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 206 | $3.02 |
| J0456 | Injection, azithromycin, 500 mg | <1% | 15 | $2.23 |
| 94760 | <1% | 1,596 | $2.08 | |
| J2305 | Injection, nitroglycerin, 5 mg | <1% | 36 | $1.42 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 0% | 970 | $0.00 |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 0% | 690 | $0.00 |
| A9541 | Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries | 0% | 110 | $0.00 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 0% | 14 | $0.00 |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 0% | 345 | $0.00 |
| C1760 | Closure device, vascular (implantable/insertable) | 0% | 401 | $0.00 |
| 00731 | 0% | 233 | $0.00 | |
| 00300 | 0% | 32 | $0.00 | |
| C1776 | Joint device (implantable) | 0% | 200 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 204 | $0.00 |
| C1751 | Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) | 0% | 75 | $0.00 |
| C1729 | Catheter, drainage | 0% | 167 | $0.00 |
| 88302 | 0% | 17 | $0.00 | |
| 00811 | 0% | 20 | $0.00 | |
| C1769 | Guide wire | 0% | 1,440 | $0.00 |
| C1889 | Implantable/insertable device, not otherwise classified | 0% | 119 | $0.00 |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | 0% | 17 | $0.00 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 0% | 370 | $0.00 |
| 77001 | 0% | 119 | $0.00 | |
| J2785 | Injection, regadenoson, 0.1 mg | 0% | 661 | $0.00 |
| 95940 | 0% | 53 | $0.00 | |
| 00902 | 0% | 12 | $0.00 | |
| 00813 | 0% | 13 | $0.00 | |
| 88331 | 0% | 18 | $0.00 | |
| 87486 | 0% | 13 | $0.00 | |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 0% | 283 | $0.00 |
| C1726 | Catheter, balloon dilatation, non-vascular | 0% | 25 | $0.00 |
| 87581 | 0% | 13 | $0.00 | |
| 00790 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKO, TIMOTHY (KETTERING HEALTH CFO)
| Provider | Location | Paid |
|---|---|---|
| Dayton Osteopathic Hospital | Dayton, OH | $111.27M |
| Alliance Physicians INC | Kettering, OH | $38.76M |
| Beavercreek Medical Center | Beavercreek, OH | $30.49M |
| The Fort Hamilton Hospital | Hamilton, OH | $27.06M |
| Kettering Medical Center | Miamisburg, OH | $20.00M |
| Greene Memorial Hospital INC | Xenia, OH | $11.31M |
| Kettering Medical Center | Troy, OH | $10.83M |
| Kettering Independent Medical Group INC | Miamisburg, OH | $8.39M |
| Kettering Affiliated Health Services | Miamisburg, OH | $2.12M |
| Greene Memorial Hospital, INC. | Jamestown, OH | $1.53M |
| Alliance Physicians INC | Moraine, OH | $1.42M |
| Alliance Physicians INC | Huber Heights, OH | $1.06M |
| Greene Memorial Hospital INC | Yellow Springs, OH | $843K |
| Alliance Physicians INC | Miamisburg, OH | $744K |
| Greene Memorial Hospital INC | Cedarville, OH | $703K |
| Alliance Physicians INC | Xenia, OH | $645K |
| Alliance Physicians INC | Springboro, OH | $616K |
| Alliance Physicians INC | Kettering, OH | $599K |
| Sycamore Primary Care Group | Miamisburg, OH | $564K |
| Alliance Physicians INC | Beavercreek, OH | $486K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.